Back to top

Press Releases

Zacks Equity Research

The Zacks Analyst Blog Highlights: Chevron, Cisco Systems, GlaxoSmithKline, NIKE and BP

CVX CSCO GSK NKE BP

Trades from $3

For Immediate Release

Chicago, IL – October 12, 2016 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Chevron Corp. (NYSE: (CVX - Free Report) -Free Report ), Cisco Systems, Inc. (NASDAQ: (CSCO - Free Report) -Free Report ), GlaxoSmithKline plc (NYSE: (GSK - Free Report) -Free Report ), NIKE, Inc. (NYSE: (NKE - Free Report) -Free Report ) and BP p.l.c. (NYSE: (BP - Free Report) -Free Report ).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Tuesday’s Analyst Blog:

Top Research Reports for Chevron, Cisco, GlaxoSmithKline

Today's Research Daily features research reports on 8 major stocks, including Chevron Corp. (NYSE: (CVX - Free Report) -Free Report ), Cisco Systems, Inc. (NASDAQ: (CSCO - Free Report) -Free Report ) and GlaxoSmithKline plc (NYSE: (GSK - Free Report) -Free Report ).

Chevron shares have responded more positively to the recent oil-price momentum than some of its other super-major peers given the company's oilier asset base. The stock is modestly down in the morning session today, but is up more than 15% year-to-date, which compares to the more defensively oriented Exxon's 13.5% gain in that same time period. Chevron's current oil and gas development project pipeline is among the best in the industry, boasting large, multi-year projects. The company has remained competitive by embarking on aggressive cost reduction initiatives, exiting unprofitable markets and streamlining the organization. (You can read the full research report on Chevron here>>)

Cisco shares have outperformed the broader market as well as the Tech sector this year (the stock is up 15.9% year-to-date), likely reflecting the market's greater appreciation for the networking giant's strong market position, product range, growth initiatives, new investments and attractive dividend. Additionally, overall growth prospects remain positive because of the drive toward cloud computing and increasing data flow on carrier and computing networks. Recently, Cisco and salesforce.com announced a partnership to integrate their cloud platforms. However, the increasing competition and challenges in China remain concerns. (You can read the full research report on Cisco here>>)

GlaxoSmithKline shares have outperformed its large-cap pharma peers given the company's positioning to deliver strong core earnings growth on the back of performance momentum in its new products as well as those acquired from Novartis. These should help support revenues and ease the impact of the loss of Advair sales. Glaxo’s efforts to develop its pipeline are also encouraging. Moreover, steps to increase cost efficiency and its outlook for the next five years bode well. (You can read the full research report on GlaxoSmithKline here>>)

Other noteworthy reports we are featuring today include NIKE, Inc. (NYSE: (NKE - Free Report) -Free Report ) and BP p.l.c. (NYSE: (BP - Free Report) -Free Report ).

Confidential: Best Trades from Zacks Research
Would you like to see a hand-picked "all-star" selection of investment ideas from the man who heads up Zacks' trading and investing services? Steve Reitmeister knows when key trades are about to be triggered and which of our experts has the hottest hand. Click for his prized selections right now >>

You can find all of today's stock research reports here>>

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.

Get the full Report on CVX - FREE

Get the full Report on CSCO - FREE

Get the full Report on GSK - FREE

Get the full Report on NKE - FREE

Get the full Report on BP - FREE

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact
Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.